Multiple myeloma causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{CMG}} {{AE}}{{HL}} | {{CMG}} {{AE}}{{HL}} | ||
==Overview== | ==Overview== | ||
Recent studies have found that mutations of some oncogenes such as ''MYC'' develop early in the course of plasma cell tumors. Changes in the ''RAS'' genes are more often found in myeloma cells in the bone marrow after treatment, and changes in tumor suppressor genes like the gene for ''p53'' are associated with spread to other organs. | |||
Recent studies have found that | |||
==Causes== | ==Causes== | ||
* mutations of some oncogenes such as ''MYC'' | |||
* mutations of some oncogenes such as ''RAS'' | |||
* mutations of some tumor suppressor genes such as ''the gene for p53'' | |||
== References == | == References == | ||
Revision as of 13:44, 28 June 2018
|
Multiple myeloma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Multiple myeloma causes On the Web |
|
American Roentgen Ray Society Images of Multiple myeloma causes |
|
Risk calculators and risk factors for Multiple myeloma causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
Recent studies have found that mutations of some oncogenes such as MYC develop early in the course of plasma cell tumors. Changes in the RAS genes are more often found in myeloma cells in the bone marrow after treatment, and changes in tumor suppressor genes like the gene for p53 are associated with spread to other organs.
Causes
- mutations of some oncogenes such as MYC
- mutations of some oncogenes such as RAS
- mutations of some tumor suppressor genes such as the gene for p53